The company was founded in 2001 and focuses on research and development, production, sales of veterinary biological products and animal epidemic prevention technology services. It is a key high-tech enterprise in the first batch of “National High-tech Industrialization Demonstration Projects” awarded by the National Development and Reform Commission, and is a listed company on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The company is a biomedical enterprise focusing on R&D, production, sales of veterinary biological products and animal epidemic prevention technology services. The company's main products are pig vaccines and poultry vaccines for compulsory immunization in non-countries. Corporate honors: Second prize of the National Science and Technology Progress Award, first prize of the Hubei Science and Technology Progress Award, National Key New Products, Hubei Top 100 Manufacturing Enterprises, Hubei Province's “Specialized, Special and New” Little Giant Enterprises, Top 50 Private Manufacturing Enterprises in Wuhan, Wuhan Agricultural Science and Technology Enterprises, Outstanding Private Enterprises in Wuhan City, and Leading Agricultural Enterprises in Wuhan.
No Data